Session 8: The Era of ADCs in the Treatment of NSCLC: Class Overview and Specifics of TROP2, HER3, c-MET, and CEACAM5 Investigational ADCs

Presenter(s)

• 

  Aaron Lisberg, MD

  University of California, Los Angeles